LEADER 01314nam  2200397   450 
001 9910830337803321
005 20230107151658.0
010   $a1-119-53533-6
010   $a1-119-53527-1
035   $a(MiAaPQ)EBC7070189
035   $a(Au-PeEL)EBL7070189
035   $a(CKB)24352763900041
035   $a(EXLCZ)9924352763900041
100   $a20230107d2022      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAnimal models for the development of cancer immunotherapy /$fedited by Seng-Lai Tan
210  1$aHoboken, New Jersey :$cWiley,$d[2022]
210  4$dİ2022
215   $a1 online resource (316 pages)
311 08$aPrint version: Tan, Seng-Lai Animal Models for the Development of Cancer Immunotherapy Newark : John Wiley & Sons, Incorporated,c2022 9781119535287 
320   $aIncludes bibliographical references and index.
606   $aImmunotherapy$xComplications
615  0$aImmunotherapy$xComplications.
676   $a636.089/6994
702   $aTan$b Seng-Lai
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910830337803321
996   $aAnimal models for the development of cancer immunotherapy$93946142
997   $aUNINA